![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessHarnessing ChatGPT and GPT-4 for evaluating the rheumatology questions of the Spanish access exam to specialized medical training
The emergence of large language models (LLM) with remarkable performance such as ChatGPT and GPT-4, has led to an unprecedented uptake in the population. One of their most promising and studied applications co...
-
Article
Open AccessImmune response after SARS-CoV-2 vaccination in patients with inflammatory immune-mediated diseases receiving immunosuppressive treatment
Real world data on the response to the SARS-CoV-2 vaccine in patients with immunomediated diseases (IMIDs) treated with immunesuppressants is of great interest because vaccine response may be impaired. The mai...
-
Article
Open AccessCo** with rheumatic stressors (CORS) questionnaire: Spanish translation and cross-cultural adaptation
Rheumatic and Musculoskeletal Diseases (RMDs) substantially impact the lives of patients, with complex associations between disease severity and self-perceived health status. In this regard, the Co** with Rh...
-
Article
Open AccessBAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors
Immunogenicity related to treatment with TNF inhibitors (TNFi) is one of the causes for the decreased attainment of clinical response in patients with rheumatoid arthritis (RA). The B-cell activating factor (B...
-
Article
Open AccessVaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study
Vaspin is a novel anti-inflammatory adipokine associated with cardiovascular (CV) disease and inflammation in chronic inflammatory conditions different from axial spondyloarthritis (axSpA). Given the high inci...
-
Article
Open AccessInfliximab concentrations in two non-switching cohorts of patients with inflammatory bowel disease: originator vs. biosimilar
Biosimilars are replacing originator compounds due to their similar effectiveness, safety and pharmacokinetics. Our objective was to compare the differences in pharmacokinetics and clinical outcomes between th...
-
Article
Open AccessAssociation between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis
The aim of our study was to investigate the influence of conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) and body mass index (BMI) on circulating drug levels and clinical response to t...